RWD Curtain Lifted On US Cannabinoids Information Gap, But Lawful Use Remains TBD

FDA gives directions on research needed for sufficiently robust “real world data” about non-drug products containing cannabinoids. While optimistic that real world data will help bridge information gap about the ingredients' safety, it’s also candid about the size of the gap.